Hematopathology, An Issue of Surgical Pathology Clinics

The issue of Surgical Pathology Clinics, guest edited by Mina L. Xu, will focus on Hematopathology, including EBV-associated Lymphoproliferative Disorders, Castleman lymphadenopathy, Early events in lymphoid neoplasms, Changes in cutaneous T-cell lymphoma diagnostic and prognostic considerations, Bone Pathology for Hematopathologists, Acute Leukemias of Ambiguous Lineage, Optimal minimal residual disease testing for AML, Defining boundaries between MDS, MPN, and MDS/MPN, Updates in pediatric lymphomas, New entities in gastrointestinal lymphoproliferative disorders, Prognostication in Diffuse Large B-cell Lymphomas, Histiocytic Neoplasms commonly encountered by hematopathologists, and Challenges in the diagnosis of grey zone lymphomas.

Format: Hardback
Publication date: 30 July 2019
Publisher: Elsevier - Health Sciences Division

The upcoming issue of Surgical Pathology Clinics, guest-edited by Mina L. Xu, will delve into the realm of Hematopathology, encompassing a wide range of topics. These include, but are not limited to:

EBV-associated Lymphoproliferative Disorders: This section will explore the complexities of lymphoproliferative disorders linked to the Epstein-Barr virus (EBV), including their clinical manifestations, diagnostic challenges, and treatment strategies.

Castleman Lymphadenopathy: Castleman lymphadenopathy is a rare and intriguing condition characterized by the proliferation of lymphoid cells in the lymph nodes. This issue will provide an in-depth analysis of its pathogenesis, diagnostic criteria, and management approaches.

Early Events in Lymphoid Neoplasms: Understanding the early stages of lymphoid neoplasms is crucial for accurate diagnosis and effective treatment. This section will explore the diagnostic markers, genetic abnormalities, and molecular pathways involved in the development of lymphoid malignancies.

Changes in Cutaneous T-cell Lymphoma Diagnostic and Prognostic Considerations: Cutaneous T-cell lymphoma is a diverse group of diseases with unique diagnostic and prognostic features. This issue will discuss recent advancements in the understanding and management of cutaneous T-cell lymphomas, including novel therapies and biomarker-based approaches.

Bone Pathology for Hematopathologists: Bone pathology plays a significant role in the diagnosis and management of hematological disorders. This section will cover the diagnostic challenges and nuances of bone marrow examination, as well as the evaluation of bone lesions in various hematological conditions.

Acute Leukemias of Ambiguous Lineage: Acute leukemias of ambiguous lineage (ALCL) are a group of rare and aggressive lymphoid malignancies. This issue will provide an overview of their clinical presentation, diagnostic criteria, and treatment options, including novel targeted therapies.

Optimal Minimal Residual Disease Testing for AML: Minimal residual disease (MRD) testing is a crucial tool in the management of acute myeloid leukemia (AML). This section will discuss the latest advancements in MRD testing, its role in predicting treatment outcomes, and the challenges associated with its interpretation.

Defining Boundaries between MDS, MPN, and MDS/MPN: Myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN) are closely related disorders with overlapping features. This issue will explore the diagnostic criteria, genetic abnormalities, and treatment strategies for these conditions, helping hematopathologists differentiate between them.

Updates in Pediatric Lymphomas: Pediatric lymphomas represent a diverse group of diseases affecting children. This issue will provide an update on the latest developments in the diagnosis, treatment, and prognosis of pediatric lymphomas, including novel therapies and immunotherapy approaches.

New Entities in Gastrointestinal Lymphoproliferative Disorders: Gastrointestinal lymphoproliferative disorders include a wide range of conditions affecting the lymphatic system in the gastrointestinal tract. This issue will explore the diagnostic features, clinical presentation, and treatment options for these disorders, including targeted therapies and immunotherapy.

Prognostication in Diffuse Large B-cell Lymphomas: Diffuse large B-cell lymphomas (DLBCL) are a heterogeneous group of lymphoid malignancies with aggressive behavior. This issue will discuss the latest prognostic markers, treatment algorithms, and novel therapeutic approaches for DLBCL, aiming to improve patient outcomes.

Histiocytic Neoplasms Commonly Encountered by Hematopathologists: Histiocytic neoplasms encompass a diverse group of diseases characterized by the proliferation of histiocytes. This issue will provide an overview of these neoplasms, including their diagnostic features, clinical presentation, and treatment options, including immunotherapy and targeted therapies.

Challenges in the Diagnosis of Grey Zone Lymphomas: Grey zone lymphomas are a group of lymphoid malignancies with ambiguous clinical and pathological features. This issue will discuss the diagnostic challenges, controversies, and emerging diagnostic tools for these diseases, helping hematopathologists make accurate diagnoses and develop effective treatment strategies.

In conclusion, the upcoming issue of Surgical Pathology Clinics, guest-edited by Mina L. Xu, will offer a comprehensive and up-to-date perspective on Hematopathology, covering a wide range of topics and providing valuable insights for healthcare professionals.

Weight: 295g
ISBN-13: 9780323682275